|Articles|December 13, 2011

Marken Announces Its New Logistics Operation System: Maestro

Marken announced that it has significantly upgraded its existing operating system with a centralized web-based software exclusively designed for its growing supply chain organization. The system, known as ‘Maestro’ has a flexible architecture which will enable extensive tracking of shipments, integrated documentation, client reporting, and performance monitoring. It is designed explicitly for ease of integration with client’s systems to meet their growing requirements with temperature and time sensitive drugs to be shipped worldwide. Its interfaces and flexible structure enables each of its clients to input and track relevant data connected with a clinical trial and manage the hand-offs between shipments from site to lab and country to country. This new operating system, when coupled with Marken’s new Solo™ system for its depot operations, will allow Marken to manage the complete inbound and outbound cycle for clinical trials.

“We are very proud to announce the new Maestro system to our clients”, said Cyril Leger, Chief Operating Officer, Marken LLC. “We have been working on this new system for many months and have incorporated our best thinking as well as feedback from our clients. Our customer service representatives can now work more efficiently around the clock, across all of our 24 branch locations, and track shipments more precisely than ever before”.


Related to this article

© photon_photo - © photon_photo - stock.adobe.com
Standardized measurement across five oncology centers found that clinical research coordinators rated eSource-enabled workflows positively (Overall Mean Satisfaction 5.79 of 7), with reduced manual entry and electronic data transfer earning strong marks, while perceived reduction in sponsor and monitor queries lagged as the one domain below threshold.
Where the Industry Is Headed as Clinical, Operational, and Real-World Data Connect
In this video interview, Rajneesh Patil, global head of AI, digital, and innovation in clinical development at Syneos Health, describes the industry’s trajectory toward a unified intelligence orchestration environment—and explains why the future isn’t one model that knows everything, but a trusted system that brings the right evidence to the right human decision.
What Expanding AI Ecosystems Mean for Sponsor Complexity and Oversight
In this video interview, Rajneesh Patil, global head of AI, digital, and innovation in clinical development at Syneos Health, argues that CROs must act as orchestrators rather than aggregators—and that the real test of any AI ecosystem is whether it reduces sponsor coordination burden or just hands it back to them.